NYSE · HAE
Haemonetics Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for HAE: Nov 05, 2026
Haemonetics Corporation Common Stock is expected to report earnings on 11/05/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $1.3. The reported EPS for the same quarter last year was $1.27.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $1.30 | $1.37 | $1.25 | 6 |
| Dec 2026 | $1.36 | $1.43 | $1.28 | 5 |
| Mar 2027 | $1.48 | $1.62 | $1.34 | 5 |
| Jun 2027 | $1.26 | $1.27 | $1.25 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · RTTNews · Barchart- Zacks · Oct 29, 10:40 AM EDTGEHC vs. HAE: Which Stock Is the Better Value Option?GEHC vs. HAE: Which Stock Is the Better Value Option?
- Zacks · Oct 27, 11:00 AM EDTAll You Need to Know About Haemonetics (HAE) Rating Upgrade to BuyHaemonetics (HAE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Fintel · Oct 22, 11:53 PM EDTHaemonetics Consensus Price Target Raised 24.88% to $145.63The average one-year price target for Haemonetics (NYSE:HAE) (DB:HAZ) has been revised to $145.63 / share. This is an increase of 24.88% from the prior estimate of $116.62 dated September 29, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not co
- RTTNews · Oct 20, 12:32 AM EDTFDA Approves Haemonetics' PerQseal Elite For Large-Bore Arterial Procedures(RTTNews) – Haemonetics Corp. (HAE), a medical technology company, announced the U.S. Food and Drug Administration (FDA) approval of the PerQseal Elite vascular closure system for large-bore arterial procedures.
- Zacks · Oct 16, 7:14 AM EDTHaemonetics Gains 149.3% in a Year: What's Driving the Rally?HAE shares surged 149.3% in a year, fueled by strong Plasma and MedSurg growth, rising product demand and an upbeat fiscal 2027 revenue outlook.
- Zacks · Oct 15, 8:28 AM EDTIs it Apt to Retain Haemonetics Stock in Your Portfolio for Now?HAE's MedSurg growth and NexSys PCS adoption support its prospects, but competitive pressures and unfavorable currency movements pose risks.
- Zacks · Oct 13, 8:50 AM EDTWhy Haemonetics (HAE) is a Top Momentum Stock for the Long-TermWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- Barchart · Oct 9, 2:14 PM EDTBroader Market Settles Lower on Soaring Crude Prices and Chipmaker WeaknessThe S&P 500 Index ($SPX ) (SPY ) closed down by -0.47% on Thursday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.39%. December E-mini S&P futures (ESZ26 ) fell -0.41%, and December E-mini…
- BNK Invest · Oct 9, 6:45 AM EDTHAE Crosses Above Average Analyst TargetIn recent trading, shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $110.45, changing hands for $119.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v
- Zacks · Oct 9, 6:43 AM EDTStrength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?Haemonetics (HAE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- RTTNews · Oct 9, 6:29 AM EDTBiotech Stocks At 52-Week Highs – PCRX +44% On Acquisition News; MANE+14%, HAE+17%, CON, HSTM(RTTNews) – The following biotech stocks reached a 52-week high on October 8, 2026, driven by catalysts such as reports of an upcoming acquisition or upcoming financial reports.
- Barchart · Oct 8, 6:27 PM EDTStocks Pressured by Soaring Crude Oil PricesThe S&P 500 Index ($SPX ) (SPY ) is down by -0.26% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.42%. December E-mini S&P futures (ESZ26 ) are down -0.30%, and December E-mini…
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Haemonetics Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.